France’s Government Takes Major Step Towards Medical Cannabis Generalisation
Following months of uncertainty and doubt, thousands of medical cannabis patients in France can now breathe a sigh of relief after the government finally confirmed that access to their treatment will continue.
On Monday, October 23, the government tabled an amendment to the Social Security Financing Bill (PLFSS) concerning medical cannabis, bringing it into France’s general medical framework for the first time.
Now, according to the new proposals, medical cannabis products will receive a ‘temporary authorisation’ for five years, with scope for these to be renewed by French authorities indefinitely.
Benjamin-Alexandre Jeanroy of Paris-based Augur Associates told Business of Cannabis that while this represents a step towards fully-fledged generalisation, it ‘is a very important step because it brings medical cannabis into general law’.
